FLT3 Gene Mutation Quantitative Monitor Test
Introduction
The FLT3 Gene Mutation Quantitative Monitor Test is a crucial diagnostic tool used in the management of leukemia. This test is essential for detecting mutations in the FLT3 gene, which can influence treatment decisions and patient outcomes. Understanding the presence of these mutations allows healthcare providers to tailor therapies effectively, making this test an integral part of leukemia management.
What the Test Measures
This test specifically measures the presence and quantity of FLT3 gene mutations in a patient’s blood or bone marrow sample. FLT3 mutations are often associated with acute myeloid leukemia (AML) and can indicate the aggressiveness of the disease.
Who Should Consider This Test
Patients diagnosed with leukemia, particularly those with acute myeloid leukemia (AML), should consider this test. Symptoms that may prompt testing include:
- Fatigue and weakness
- Frequent infections
- Easy bruising or bleeding
- Unexplained weight loss
Risk factors include a family history of leukemia or previous exposure to chemotherapy or radiation therapy.
Benefits of Taking the Test
- Helps in monitoring treatment response in leukemia patients.
- Guides healthcare providers in making informed decisions regarding therapy adjustments.
- Enables early detection of disease relapse.
- Provides valuable information for personalized medicine approaches.
Understanding Your Results
Results from the FLT3 Gene Mutation Quantitative Monitor Test will indicate the presence and level of FLT3 mutations. A higher level of mutations may suggest a more aggressive form of leukemia and may require more intensive treatment. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
Price Type | Amount (KSh) |
---|---|
Discount Price | 9,000 |
Regular Price | 13,000 |
Sample Collection and Instructions
For this test, a sample of 5 mL (3 mL minimum) of whole blood or bone marrow is required, collected in a Lavender Top (EDTA) tube. It is crucial to ship the sample refrigerated and to avoid freezing. Additionally, a duly filled MRD Requisition Form (Form 22) with historical data is mandatory for processing.
Turnaround Time
Samples should be submitted on Mondays or Thursdays by 11 AM, with reports available on Wednesdays or Saturdays.
Book Your Test Today
We have branches across all major cities in Kenya, and we also offer home sample collection services for your convenience. To book the FLT3 Gene Mutation Quantitative Monitor Test or for more information, please call or WhatsApp us at +254711564616.